The ARQL chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ARQL chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ARQL stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ARQL Detailed Price Forecast - CNN Money||View ARQL Detailed Summary - Google Finance|
|View ARQL Detailed Summary - Yahoo! Finance||View ARQL Stock Research & Analysis - Zacks.com|
|View ARQL Trends & Analysis - Trade-Ideas||View ARQL Major Holders - Barrons|
|View ARQL Call Transcripts - NASDAQ||View ARQL Breaking News & Analysis - Seeking Alpha|
|View ARQL Annual Report - CompanySpotlight.com||View ARQL OTC Short Report - OTCShortReport.com|
|View ARQL Fundamentals - TradeKing||View ARQL SEC Filings - Bar Chart|
|View Historical Prices for ARQL - The WSJ||View Performance/Total Return for ARQL - Morningstar|
|View the Analyst Estimates for ARQL - MarketWatch||View the Earnings History for ARQL - CNBC|
|View the ARQL Earnings - StockMarketWatch||View ARQL Buy or Sell Recommendations - MacroAxis|
|View the ARQL Bullish Patterns - American Bulls||View ARQL Short Pain Metrics - ShortPainBot.com|
|View ARQL Stock Mentions - StockTwits||View ARQL Stock Mentions - PennyStockTweets|
|View ARQL Stock Mentions - Twitter||View ARQL Investment Forum News - Investor Hub|
|View ARQL Stock Mentions - Yahoo! Message Board||View ARQL Stock Mentions - Seeking Alpha|
|View Insider Transactions for ARQL - SECform4.com||View Insider Transactions for ARQL - Insider Cow|
|View ARQL Major Holdings Summary - CNBC||View Insider Disclosure for ARQL - OTC Markets|
|View Insider Transactions for ARQL - Yahoo! Finance||View Institutional Holdings for ARQL - NASDAQ|
|View ARQL Stock Insight & Charts - FinViz.com||View ARQL Investment Charts - StockCharts.com|
|View ARQL Stock Overview & Charts - BarChart||View ARQL User Generated Charts - Trading View|
Blog Exposure - ArQule Signed License Agreement with Roivant Sciences to Develop Derazantinib In China
Posted on Friday February 09, 2018
Stock Monitor: Regeneron Pharma Post Earnings Reporting LONDON, UK / ACCESSWIRE / February 09, 2018 / Active-Investors.com has just released a free research report on ArQule, Inc. (NASDAQ: ARQL ). If you ...
ArQule to Present at The Leerink Partners 7th Annual Global Healthcare Conference on February 15, 2018
Posted on Thursday February 08, 2018
ArQule, Inc. today announced that Paolo Pucci, Chief Executive Officer, and Dr. Brian Schwartz, Chief Medical Officer and Head of Research and Development, will present at the Leerink Partners 7th Annual Global Healthcare Conference on February 15th, 2018, at 9:00 a.m.
BRIEF-Roivant Sciences And Arqule Enter Into License Agreement For Derazantinib In China
Posted on Wednesday February 07, 2018
Feb 7 (Reuters) - Arqule Inc: * ROIVANT SCIENCES AND ARQULE ENTER INTO LICENSE AGREEMENT FOR DERAZANTINIB IN CHINA * ARQULE INC - DEAL TERMS INCLUDE AN UPFRONT PAYMENT TO ARQULE OF $3 MILLION AND AN ADDITIONAL ...
Roivant Sciences and ArQule Enter into License Agreement for Derazantinib in China
Posted on Wednesday February 07, 2018
Roivant Sciences and ArQule, Inc. today announced the initiation of a collaboration to pursue the development of derazantinib, a pan-FGFR inhibitor, in Greater China.